1. Association between contrast enhancement on contrast‑enhanced CT and lenvatinib effectiveness in hepatocellular carcinoma
   Shusuke Okamura et al, 2021, Molecular and Clinical Oncology CrossRef
2. Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study
   Shigeo Shimose et al, 2020, Cancers CrossRef
3. Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study
   Shigeo Shimose et al, 2021, Cancers CrossRef
4. Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects
   Takuji Torimura et al, 2021, Clinical and Molecular Hepatology CrossRef
5. Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
   Hironori Koga et al, 2023, Clinical and Molecular Hepatology CrossRef